FBIO
Fortress Biotech, Inc.NASDAQHealthcare$2.60+5.26%ClosedMarket Cap: $80.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.40
P/S
1.23
EV/EBITDA
-3.04
DCF Value
$-1.26
FCF Yield
-128.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
50.1%
Operating Margin
-111.0%
Net Margin
-1.4%
ROE
-2.1%
ROA
-0.5%
ROIC
-50.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $16.1M | 0.0% | $-4.6M | $-11.7M | $-0.15 | — |
| FY 2025 | $61.2M | 0.0% | $-70.2M | $-32.9M | $-0.07 | — |
| Q3 2025 | $17.6M | 67.4% | $-6.8M | $5.8M | $0.11 | — |
| Q2 2025 | $16.4M | 69.9% | $-36.5M | $15.5M | $0.45 | — |
| Q1 2025 | $13.1M | 63.5% | $-22.3M | $-10.6M | $-0.48 | — |
| Q4 2024 | $15.1M | 61.6% | $-27.3M | $-6.8M | $-0.37 | — |
| FY 2024 | $57.7M | 63.8% | $-110.4M | $-46.0M | $-2.69 | — |
| Q3 2024 | $14.6M | 63.9% | $-22.1M | $-12.9M | $-0.76 | — |
| Q2 2024 | $14.9M | 56.1% | $-27.8M | $-10.9M | $-0.73 | — |
| Q1 2024 | $13.0M | 53.9% | $-36.6M | $-15.4M | $-1.03 | — |
| Q4 2023 | $19.9M | 69.8% | $-19.6M | $-9.3M | $-1.19 | — |
| FY 2023 | $84.5M | 72.9% | $-142.3M | $-60.6M | $-8.47 | — |